戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1 ears to be an independent variable affecting ASGP-R activity.
2 cubation of PHUECs in asialofetuin (ASF), an ASGP-R ligand, significantly reduced invasion.
3 between lacto-N-neotetraose-terminal LOS and ASGP-R allows gonococcal entry into PHUECs.
4 the physiologic relationship between PSS and ASGP-R activity may aid in the interpretation of quantit
5 o determine the relationship between PSS and ASGP-R density in the absence of parenchymal disease.
6 taken a genetic approach using wild-type and ASGP-R-deficient mice to determine that the ASGP-R in vi
7                                           As ASGP-R-mediated endocytosis is clathrin dependent, clath
8         The pH dissociation profiles of ASOR.ASGP-R complexes were also identical for complexes conta
9 n that content of plasma membrane-associated ASGP-R is decreased after ethanol exposure, although the
10  binding is based on the correlation between ASGP-R density and hepatic functional reserve.
11                                     For both ASGP-R and APN and for both treatments, the block in tra
12 y transfected SK-Hep-1 cell lines expressing ASGP-R complexes containing H1 and either H2b or H2c had
13  mutant LOS lacking the galactose ligand for ASGP-R.
14 05) in the presence of antibody specific for ASGP-R as well as the introduction of competing sugars i
15 eloped a novel fluorescent polarization (FP) ASGP-R binding assay to determine the binding affinities
16 rat hepatic lectins (RHL) 1, 2, and 3; human ASGP-R contains two subunits, HHL1 and HHL2.
17 ecular weight corresponding to that of human ASGP-R.
18      In summary, the H2 subunit of the human ASGP-R contains functional, although weak, signal(s) for
19                                    The human ASGP-R contains two subunits, H1 and H2.
20                                    The human ASGP-R is a hetero-oligomeric complex composed of H1 and
21                                    The human ASGP-R is a hetero-oligomeric complex composed of two su
22                            TSA also impaired ASGP-R endocytic trafficking, but to a lesser extent.
23 e the sequences of subunits in all mammalian ASGP-R species are highly conserved especially at the re
24                                     The mean ASGP-R density (nmol/g of liver) was significantly decre
25 heart time-activity data was used to measure ASGP-R concentration, as well as hepatic plasma volume a
26 e to investigate the capability of the minor ASGP-R subunit, H2, to function independently of H1, bec
27 assay to determine the binding affinities of ASGP-R-targeted molecules.
28 study was to further clarify the capacity of ASGP-R to phagocytose apoptotic cells in relationship to
29 de in the carbohydrate recognition domain of ASGP-R but not preimmune antibody.
30 hway, such as transcytosis, for the entry of ASGP-R.ASOR complexes into these cells.
31 s based on using the three-pronged ligand of ASGP-R as a computational probe to derive the 3D conform
32                           Co-localization of ASGP-R with gonococci was observed.
33 Siaalpha2,6Gal are elevated in the plasma of ASGP-R-deficient mice.
34       This work demonstrates the presence of ASGP-R on human sperm.
35         In order to study the function(s) of ASGP-R palmitoylation, we mutated these Cys residues to
36 e preparations from rat liver as a source of ASGP-R and Cy5 fluorophore-labeled triGalNAc synthetic l
37 re compatible with the trimeric structure of ASGP-R.
38 ion may be related to altered trafficking of ASGP-R.
39 s no effect on ER-to-Golgi transportation of ASGP-R, however, it results in its deposition in cis-med
40 e Golgi-to-plasma membrane transportation of ASGP-R.
41  constitutive recycling of hetero-oligomeric ASGP-R complexes.
42 resent with H1 in the same hetero-oligomeric ASGP-R complexes.
43                          Binding of purified ASGP-R ligand decreased in the presence of gonococci.
44        Following deglycosylation of purified ASGP-R, we detected the H2b and H2c proteins in HepG2 an
45                                          Rat ASGP-R contains three subunits, designated rat hepatic l
46              We have determined that the rat ASGP-R specifically binds oligosaccharides terminating w
47  on the newly defined specificity of the rat ASGP-R we hypothesize that glycoproteins bearing structu
48  blood may be endogenous ligands for the rat ASGP-R.
49 owed that human asialoglycoprotein receptor (ASGP-R) and the terminal lactosamine of lacto-N-neotetra
50       Using the asialoglycoprotein receptor (ASGP-R) as a model, we have previously shown decreased b
51 niques that use asialoglycoprotein receptor (ASGP-R) binding is based on the correlation between ASGP
52 tibodies to the asialoglycoprotein receptor (ASGP-R) demonstrated the presence of this receptor on in
53                 Asialoglycoprotein receptor (ASGP-R) has been actively investigated for targeted deli
54  the liver, the asialoglycoprotein receptor (ASGP-R) has been shown to be involved in the phagocytosi
55 hologues of the asialoglycoprotein receptor (ASGP-R) in different mammals differ in their specificity
56     The hepatic asialoglycoprotein receptor (ASGP-R) internalizes desialylated glycoproteins via the
57 l human hepatic asialoglycoprotein receptor (ASGP-R) is a hetero-oligomer composed of two subunits, d
58             The asialoglycoprotein receptor (ASGP-R) is an abundant, carbohydrate-specific, endocytic
59     The hepatic asialoglycoprotein receptor (ASGP-R) is an endocytic receptor that mediates the inter
60 mmalian hepatic asialoglycoprotein receptor (ASGP-R) is an endocytic recycling receptor that mediates
61     The hepatic asialoglycoprotein receptor (ASGP-R) is posttranslationally modified in the Golgi en
62 can bind to the asialoglycoprotein receptor (ASGP-R) on human sperm.
63 fficking of the asialoglycoprotein receptor (ASGP-R) was impaired in ethanol-treated WIF-B cells.
64  ligands of the asialoglycoprotein receptor (ASGP-R), thyroglobulin, asialothyroglobulin, and antibod
65 ctable trimeric asialoglycoprotein receptor (ASGP-R), which consists of human hepatic subunits (two s
66 ntified for the asialoglycoprotein receptor (ASGP-R), which is abundantly expressed by parenchymal ce
67 ytes called the asialoglycoprotein receptor (ASGP-R), which is known to have a high affinity for spec
68 zed through the asialoglycoprotein receptor (ASGP-R).
69             The asialoglycoprotein-receptor (ASGP-R) located on liver parenchymal cells was originall
70 that H2b and H2c are not present in the same ASGP-R complexes with H1.
71 study provides detailed information about TA-ASGP-R interactions and the symmetry of the complex.
72               Microscopy studies showed that ASGP-R traffics to the cell surface after gonococcal cha
73 olated the receptor and identified it as the ASGP-R.
74  require desialylation before removal by the ASGP-R on hepatocytes.
75                           In conclusion, the ASGP-R is involved in the recognition and uptake of apop
76 e basis of their relative affinities for the ASGP-R and their relative abundance.
77 nor has a naturally occurring ligand for the ASGP-R been identified.
78 GalNAc); however, endogenous ligands for the ASGP-R have not to date been definitively identified.
79 iaalpha2,6Gal are endogenous ligands for the ASGP-R, and that the ASGP-R helps to regulate the relati
80                  A significant change in the ASGP-R density occurs with PSS in the absence of parench
81 ng either both (hH1 and hH2) subunits of the ASGP-R (3T3-22Z cells) or both hH1 and a functionally de
82 re, we have determined that subunit 1 of the ASGP-R accounts for the binding of terminal Siaalpha2,6G
83             The recombinant subunit 1 of the ASGP-R from the rat (RHL-1 or rat hepatic lectin) and th
84 epatocytes expressing the hH1 subunit of the ASGP-R fused to green fluorescent protein, we could show
85 from the circulation, and the ability of the ASGP-R hepatic lectin-1 subunit to bind SiaGGnM-BSA, we
86  and antibody binding characteristics of the ASGP-R in rats fed ethanol over a 5-week time course.
87       We conclude that palmitoylation of the ASGP-R is required for its efficient endocytosis of liga
88     In summary, an early inactivation of the ASGP-R occurs during ethanol exposure followed by an act
89 thanol feeding, biosynthetic labeling of the ASGP-R was decreased in the ethanol cells, indicating im
90  cells, indicating impaired synthesis of the ASGP-R.
91 ng terminal Siaalpha2,6Gal will saturate the ASGP-R and compete with each other on the basis of their
92 ogenous ligands for the ASGP-R, and that the ASGP-R helps to regulate the relative concentration of s
93  ASGP-R-deficient mice to determine that the ASGP-R in vivo does indeed account for the rapid clearan
94             We have also determined that the ASGP-R is able to bind core-substituted oligosaccharides
95                   Our data indicate that the ASGP-R is initially inactivated during the time course o
96            We recently demonstrated that the ASGP-R mediates the clearance of glycoproteins bearing S
97                          We propose that the ASGP-R mediates the clearance of glycoproteins that bear
98                  These data suggest that the ASGP-R on human sperm cells recognizes and binds wild-ty
99                                    Thus, the ASGP-R appears to directly participate in the rapid in v
100  a fluorescent-labeled probe specific to the ASGP-R mRNA demonstrated this message in uninfected and
101 alofetuin, which can selectively bind to the ASGP-R.
102  proteins bind to and cointernalize with the ASGP-R in cultured human hepatocytes.
103 ral ligand readily able to interact with the ASGP-R.
104 s spent in determining binding affinities to ASGP-R.
105 (e.g., triGalNAc) bind with high affinity to ASGP-R and, when conjugated to a therapeutic agent, can
106            Reaction of hydroxylamine-treated ASGP-R with [14C]iodoacetamide resulted in the specific
107 ury as altered uptake of apoptotic cells via ASGP-R may result in the release of proinflammatory medi

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top